Berberine in Dermatology: A Natural Ally for Complex Skin Conditions? Berberine, a plant-derived alkaloid long used in traditional medicine, is gaining traction as a complementary therapy in dermatology. With its…
Post-Surgical Bleeding in Dermatology: Risk, Management, and Intervention Postoperative bleeding is one of the most common complications in dermatologic surgery, potentially leading to hematoma formation and impaired healing. While careful…
ICI Therapy and Hair Loss: A Rare but Impactful Side Effect Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, empowering the immune system to target tumors more effectively. But with…
Microbiome Matters: Can Your Moisturizer Restore Balance? The skin microbiome is more than just a trendy buzzword - it is a critical player in the pathophysiology of atopic dermatitis and…
A Message From the Editor-in-Chief Dear Colleagues, The March issue of the Journal of Drugs in Dermatology highlights a diverse range of topics that reflect our specialty's dynamic and evolving…
Featured Video Abstract Check out our all new video abstract from Patricia K. Farris, MD, where she discusses acetyl dipeptide-31 amide as a novel cosmetic anti-inflammatory peptide that demonstrates anti-aging,…
Featured Podcast What a time to be a psoriasis patient, decades into the golden age of management strategies. With an embarrassment of treatment riches, all patients are clear right? Slow…
Intralesional Steroids vs. Cryotherapy: Which Wins for Alopecia Areata? Alopecia Areata (AA) remains an enigmatic condition with treatment options offering varying degrees of success. While intralesional corticosteroids are the first-line treatment,…
Hyaluronidase and HA Fillers: Does One Dose Fit All? Not all HA fillers dissolve the same way. A new study reveals that HA concentration is key in determining hyaluronidase effectiveness,…
Trending Article We know cold weather dries out skin, but did you know it can also cause full-blown medical conditions? Cold temperatures compromise the skin’s barrier, triggering inflammation, water loss,…
Access Denied: Medicaid’s Barrier to Dermatologic Treatment Vitiligo and alopecia areata (AA) are not just cosmetic concerns—they profoundly affect patients' quality of life. While the FDA has approved innovative JAK inhibitors…